Business Context and Reporting Period
This Form 8-K is a current report filed by Inspire Medical Systems, Inc. on July 18, 2024. The filing addresses a significant change in executive leadership under Item 5.02.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
Philip J. Ebeling has resigned as Chief Operating Officer, effective August 9, 2024. Mr. Ebeling joined the company in June 2020. The departure is to pursue a new role as President and CEO of a private medical device company in the cardiology sector. The company states the resignation is not due to any dispute regarding operations, policies, or practices.
Outlook and Management Commentary
Management intends to commence a search for a new Chief Operating Officer with the assistance of a leading executive search firm. No specific guidance, risks, or contingencies related to financial performance were disclosed in this filing.
Investor Verification Checklist
- Confirm the effective date of the COO resignation (August 9, 2024).
- Monitor subsequent announcements regarding the appointment of an interim or permanent replacement.
- Review the company's most recent 10-Q or 10-K for financial metrics not included in this 8-K.